 |
|
| DRUG-DRUG INTERACTIONS: SCIENTIFIC AND REGULATORY PERSPECTIVES, 43
| |
| | |
|
|
To order this title, and for more information, click here
J. August, John Hopkins University; Department of Pharmacology, Baltimore, Maryland, U.S.A.
Albert Li, In Vitro Technologies, Inc., and University of Maryland Technology Center, Baltimore, Maryland, U.S.A.
Ferid Murad, University of Texas Medical School, Houston, U.S.A.
M. Anders, University of Rochester; Department of Pharmacology, New York, U.S.A.
Joseph Coyle, McLean Hospital, Harvard Medical School, Belmont, Massachusetts, U.S.A.
Included in series
Advances in Pharmacology,
Description
Drug–Drug Interactions is a comprehensive review of the scientific and regulatory perspectives of drug–drug
interactions from the point-of-view of academia, industry, and government regulatory agencies. This book is intended for professionals
in the pharmaceutical industry, health care, and governmental regulatory agencies. Topics of interest include the mechanistic understanding
of drug–drug interactions, the prediction of drug–drug interaction potential of new drugs, and the avoidance of clinically
significant drug–drug interaction in patients.
Audience
Professionals in the pharmaceutical industry, health care industry, and governmental regulatory agencies. Students and researchers in
the areas of pharmacology, toxicology, pharmacokinetics, and medicine.
Contents
J. Collins, Foreword.A.P. Li, Preface.A.P. Li, Overview: Scientific Basis of Pharmacokinetic Drug-Drug Interactions.
F.P. Guengerich, Role of Cytochrome P450 Enzymes in Drug-Drug Interactions.J.M. Sauer, E.R. Stine, L. Gunawardhana, D.A.
Hill, and I.G. Sipes, The Liver as a Target for Chemical-Chemical Interactions.A.D. Rodrigues and S.L. Wong, Applications
of Human Liver Microsomes in Metabolism-Based Drug-Drug Interactions.A.P. Li, Applications of Human Hepatocytes as an Experimental
System for the Evaluation of Pharmacokinetic Drug-Drug Interactions.J.L. Ferrero and K. Brendal, Liver Slices as a Model in
Drug Metabolism and Drug-Drug Interactions.C.L. Crespi and B.W. Penman, The Use of cDNA Expressed Human Cytochrome P450 Enzymes
to Study Potential Drug-Drug Interactions.G.L. Kedderis, Pharmacokinetics of Drug Interactions.T.N. Thompson, Experimental
Models for Evaluating Enzyme Induction Potential of New Drug Candidates in Animals and Man and a Strategy for Their Use.J.D. Balian,
Metabolic Drug-Drug Interactions: Perspective from U.S. FDA Medical and Clinical Pharmacology Reviewers.M. Jurima-Romet, Drug
Interactions: Perspectives of the Canadian Directorate.
| Bibliographic details |
Hardbound, 304 pages, publication date: OCT-1997
ISBN-13: 978-0-12-032944-1
ISBN-10: 0-12-032944-1
Imprint: ACADEMIC PRESS
|
| Price and Ordering |
Price:
GBP 135.99
USD 225
EUR 160.95
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
999/999
Last update: 3 Oct 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company